Trial
NCT04854044
ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Jonsson Comprehensive Cancer Center
Collaborators
National Cancer Institute (NCI); Oncoceutics, Inc.; University of California, Los Angeles
Condition
Recurrent Glioblastoma
Intervention
Akt/ERK Inhibitor ONC201
Why stopped
The P.I. is not prepared to move forward at this thime
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-05-12